Delivery Order SPE2DB22D3301-SPE2DB25FY7QA

Award Date 7/10/25
Potential Completion Date 7/11/25
Potential Value $4.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,819.58 firm fixed-price delivery order is for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a prescription medication. The contract has an ultimate completion date of September 6, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, a global pharmaceutical sourcing and distribution services company. The $1,789.07 firm fixed price delivery order is for 4563830856, described as OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, to be delivered by March 4, 2024. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp by DLA,...
This federal contract award is a delivery order placed with Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,943.70 firm fixed-price contract is for the delivery of 250 mcg/0.5 ml syringes of the medication Ovidrel, with a completion date of May 20, 2025. The contract is not set aside and is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen with the DLA...
This is a delivery order (SPE2DB22D3501|SPE2DB25FTU24) awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,125.99 firm fixed-price contract is for the supply of 4566693062 - OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, with a completion date of December 12, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product. The contract has a ceiling value of $3,585.48 and is a firm fixed-price delivery order. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen Drug Corp holds a significant...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, provides the Defense Logistics Agency (DLA) Troop Support Medical with pharmaceutical products and medical supplies, primarily in the form of firm fixed price delivery orders. The award, valued at up to $3,964.50, is for the procurement of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a specialty pharmaceutical. The contract has an ultimate completion date of March 22, 2024 and was awarded on March...
This federal contract award to Amerisourcebergen Drug Corp (Amerisourcebergen) was issued by the Defense Logistics Agency (DLA), a defense agency, for the delivery of 4,565,332,650 units of the pharmaceutical product OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The contract has a ceiling value of $2,474.85 and is a Firm Fixed Price Delivery Order. The contract has an ultimate completion date of August 5, 2024, and was awarded on August 2, 2024. Amerisourcebergen, a major pharmaceutical distributor,...
This federal contract award is a $3,281.28 delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the provision of 250 mcg/0.5 mL syringes of the drug Ovidrel, with a period of performance running through December 16, 2024. This order is placed against AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, with the ID SPE2DB22D1106|SPE2DB24FFKK9, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The contract is for the delivery of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML, a pharmaceutical product, with a ceiling value of $4,066.82 and a completion date of September 3, 2024. The contract is a Firm Fixed Price Delivery Order and does not have a set-aside designation. Amerisourcebergen Drug Corp, a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,697.52 firm fixed-price delivery order is for the supply of 250 mcg/0.5 mL syringes of the pharmaceutical product Ovidrel. The award does not have a set-aside designation. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and...
  • SPE2DB22D3301
    Indefinite Delivery Contract
  • SPE2DB22D3301-SPE2DB25FY7QA
    Delivery Order

This federal contract award is a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of OVIDREL 250 MCG/0.5 ML SYRG 0.5ML. The $4,201.80 firm fixed price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, with a performance period ending on July 11, 2025. The contract is not set aside for any specific business type.

Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This IDC enables Amerisourcebergen to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.

Generated 10/12/25, 1:06 AM